148 related articles for article (PubMed ID: 1190753)
1. Viral keratitis-inhibitory effect of 9-beta-D-arabinofuranosylhypoxanthine 5'-monophosphate.
Sidwell RW; Allen LB; Huffman JH; Revankar GR; Robins RK; Tolman RL
Antimicrob Agents Chemother; 1975 Oct; 8(4):463-7. PubMed ID: 1190753
[TBL] [Abstract][Full Text] [Related]
2. Effect of 9-beta-D-arabinofuranosyladenine 5'-monophosphate and 9-beta-D-arabinofuranosylhypoxanthine 5'-monophosphate on experimental herpes simplex keratitis.
Kaufman HE; Varnell ED
Antimicrob Agents Chemother; 1976 Dec; 10(6):885-8. PubMed ID: 1008546
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of experimental deoxyribonucleic acid virus-induced encephalitis by 9-beta-D-arabinofuranosylhypoxanthine 5'-monophosphate.
Allen LB; Thompson JM; Huffman JH; Revankar GR; Tolman RL; Simon LN; Robins RK; Sidwell RW
Antimicrob Agents Chemother; 1975 Oct; 8(4):468-73. PubMed ID: 172008
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of 9-beta-D-arabinofuranosylhypoxanthine 5'-monophosphate in therapy of equine abortion virus-induced hepatitis in hamsters.
Allen LB; Huffman JH; Revankar GR; Tolman RL; Simon LN; Robins RK; Sidwell RW
Antimicrob Agents Chemother; 1975 Oct; 8(4):474-8. PubMed ID: 172009
[TBL] [Abstract][Full Text] [Related]
5. Comparative efficacy of 5-methoxymethyl-2'-deoxyuridine, 9 beta-D-arabinofuranosyladenine and 5-iodo-2'-deoxyuridine in the treatment of experimental herpes simplex keratitis.
Meldrum JB; Gupta VS; Babiuk LA
Chemotherapy; 1980; 26(1):54-63. PubMed ID: 7353440
[TBL] [Abstract][Full Text] [Related]
6. Antiviral activity in the rabbit cornea of adenine arabinoside, Ara-A 5' monophosphate, and hypoxanthine arabinoside; and interactions with adenosine deaminase inhibitor.
Falcon MG; Jones BR
J Gen Virol; 1977 Jul; 36(1):199-202. PubMed ID: 196039
[TBL] [Abstract][Full Text] [Related]
7. Effect of 1-beta-D-ribofuranosyl1-1,2,4-triazole-3-carboxamide (virazole, ICN 1229) on herpes and vaccinia keratitis and encephalitis in laboratory animals.
Sidwell RW; Allen LB; Khare GP; Huffman JH; Witkowski JT; Simon LN; Robins RK
Antimicrob Agents Chemother; 1973 Feb; 3(2):242-6. PubMed ID: 4790589
[TBL] [Abstract][Full Text] [Related]
8. Effect of iontophoretic and topical application of antiviral agents in treatment of experimental HSV-1 keratitis in rabbits.
Kwon BS; Gangarosa LP; Park NH; Hull DS; Fineberg E; Wiggins C; Hill JM
Invest Ophthalmol Vis Sci; 1979 Sep; 18(9):984-8. PubMed ID: 90030
[TBL] [Abstract][Full Text] [Related]
9. Therapy with 9-beta-D-arabinofuranosyladenine (ARA-A) and 2'-deoxycoformycin increases the ARA-A content of ocular tissues.
O'Brien WJ
Curr Eye Res; 1986 Aug; 5(8):595-9. PubMed ID: 3489583
[TBL] [Abstract][Full Text] [Related]
10. Anti-herpes activity of adenine arabinoside monophosphate.
Trobe JD; Centifanto Y; Zam ZS; Varnell E; Kaufman HE
Invest Ophthalmol; 1976 Mar; 15(3):196-9. PubMed ID: 1254407
[TBL] [Abstract][Full Text] [Related]
11. Ara AMP- a highly soluble new antiviral drug.
Pavan-Langston D; North RD; Geary PA
Ann Ophthalmol; 1976 May; 8(5):571-9. PubMed ID: 937940
[TBL] [Abstract][Full Text] [Related]
12. Chemotherapy of herpetic keratitis induced by acyclovir-resistant strains of herpes simplex virus type 1.
O'Brien WJ; Taylor JL
Am J Med; 1982 Jul; 73(1A):294-9. PubMed ID: 6285720
[TBL] [Abstract][Full Text] [Related]
13. Acyclovir and vidarabine monophosphate: comparison of iontophoretic and intravenous administration for the treatment of HSV-1 stromal keratitis.
Hill JM; Kwon BS; Burch KD; Deback J; Whang I; Jones GT; Luke B; Harp R; Shimomura Y; Hull DS; Gangarosa LP
Am J Med; 1982 Jul; 73(1A):300-4. PubMed ID: 6179415
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory and lethal concentrations of 9-beta-D-arabinofuranosyladenine and its hypoxanthine-derivative versus herpes simplex virus, type 1.
Williams BB; Bailey EJ; Lerner AM
J Lab Clin Med; 1977 Apr; 89(4):687-91. PubMed ID: 191546
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and antiviral activity of certain 5'-monophosphates of 9-D-arabinofuranosyladenine and 9-D-arabinofuranosylhypoxanthine.
Revankar GR; Huffman JH; Allen LB; Sidwell RW; Robins RK; Tolman RL
J Med Chem; 1975 Jul; 18(7):721-6. PubMed ID: 1171242
[TBL] [Abstract][Full Text] [Related]
16. Deoxyadenosine antagonism of the antiviral activity of 9-beta-D-arabinofuranosyladenine and 9-beta-D-arabinofuranosylhypoxanthine.
Smith SH; Shipman C; Drach JC
Cancer Res; 1978 Jul; 38(7):1916-21. PubMed ID: 207416
[TBL] [Abstract][Full Text] [Related]
17. Target-organ treatment of neurotropic virus diseases: efficacy as a chemotherapy tool and comparison of activity of adenine arabinoside, cytosine arabinoside, idoxuridine, and trifluorothymidine.
Allen LB; Sidwell RW
Antimicrob Agents Chemother; 1972 Sep; 2(3):229-33. PubMed ID: 4790562
[TBL] [Abstract][Full Text] [Related]
18. [Arabinosyladenine in ophthalmology (author's transl)].
Colin J
J Fr Ophtalmol; 1981; 4(6-7):525-30. PubMed ID: 7028853
[TBL] [Abstract][Full Text] [Related]
19. Antiviral activity of arabinosyladenine and arabinosylhypoxanthine in herpes simplex virus-infected KB cells: selective inhibition of viral deoxyribonucleic acid synthesis in synchronized suspension cultures.
Shipman C; Smith SH; Carlson RH; Drach JC
Antimicrob Agents Chemother; 1976 Jan; 9(1):120-7. PubMed ID: 176927
[TBL] [Abstract][Full Text] [Related]
20. [The effect of human leukocyte interteron (HIF) on experimental viral keratitis in monkeys (author's transl)].
SundmacheR ; Neumann-Haefelin D; Shrestha B
Albrecht Von Graefes Arch Klin Exp Ophthalmol; 1975 Jul; 195(4):263-70. PubMed ID: 1080375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
